"The Stanley M. Truhlsen Eye Institute is a state-of-the-art facility that provides the latest in diagnosing and treating all eye care problems. Patients here get the latest and best care in the Midwest thanks in part to Nebraska Medicine's research and education partner, the University of Nebraska Medical Center (UNMC)."

During the past decade, UNMC Truhlsen Eye Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNMC Truhlsen Eye Institute" #1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator, "Milton S. Hershey Medical Center" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator, "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "University of Wisconsin, Madison" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "UNMC Truhlsen Eye Institute" are "Central Retinal Vein Occlusion" (1 trials), "Diabetic Retinopathy" (1 trials), "Geographic Atrophy" (1 trials), "Neovascular Macular Degeneration" (1 trials) and "Persistent Corneal Epithelial Defect" (1 trials). Many other conditions were trialed in "UNMC Truhlsen Eye Institute" in a lesser frequency.

Most popular intervention types in "UNMC Truhlsen Eye Institute" are "Drug" (3 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.67% Sodium Chloride Ophthalmic Solution" (1 trials), "Aflibercept" (1 trials), "Lampalizumab" (1 trials), "Open-label ST266" (1 trials) and "ST266" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNMC Truhlsen Eye Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "UNMC Truhlsen Eye Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UNMC Truhlsen Eye Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UNMC Truhlsen Eye Institute, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".